Fennec Pharmaceuticals Inc.
FRX.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 21.95M | 18.71M | 22.68M | 26.63M | 40.32M |
| Total Receivables | 19.34M | 17.50M | 15.45M | 12.88M | 12.91M |
| Inventory | 2.48M | 2.20M | 1.40M | 1.06M | 1.13M |
| Prepaid Expenses | 1.40M | 1.42M | 2.44M | 3.08M | 3.07M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 898.00K | 965.00K | 1.00M | 466.00K | 546.00K |
| Total Current Assets | 46.06M | 40.79M | 42.98M | 44.12M | 57.97M |
|
|
|||||
| Total Current Assets | 46.06M | 40.79M | 42.98M | 44.12M | 57.97M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.20M | 4.08M | 3.43M | 822.00K | 956.00K |
| Total Assets | 49.26M | 44.88M | 46.40M | 44.95M | 58.92M |
|
|
|||||
| Total Accounts Payable | 5.87M | 5.94M | 5.28M | 3.24M | 3.87M |
| Total Accrued Expenses | 3.70M | 2.23M | 2.84M | 3.43M | 3.31M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 2.00K | 7.00K |
| Total Finance Division Other Current Liabilities | 248.00K | 248.00K | 248.00K | 248.00K | 248.00K |
| Total Other Current Liabilities | 248.00K | 248.00K | 248.00K | 248.00K | 248.00K |
| Total Current Liabilities | 9.82M | 8.41M | 8.37M | 6.92M | 7.44M |
|
|
|||||
| Total Current Liabilities | 9.82M | 8.41M | 8.37M | 6.92M | 7.44M |
| Long-Term Debt | 19.38M | 19.36M | 19.35M | 19.34M | 32.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 24.56M | 24.56M | 24.56M | 24.56M | 24.56M |
| Total Liabilities | 53.75M | 52.34M | 52.28M | 50.82M | 64.09M |
|
|
|||||
| Common Stock & APIC | 218.90M | 215.29M | 213.72M | 212.57M | 211.28M |
| Retained Earnings | -224.64M | -224.00M | -220.85M | -219.68M | -217.70M |
| Treasury Stock & Other | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M |
| Total Common Equity | -4.49M | -7.46M | -5.88M | -5.87M | -5.17M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -4.49M | -7.46M | -5.88M | -5.87M | -5.17M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.49M | -7.46M | -5.88M | -5.87M | -5.17M |
|
|
|||||